Global Neurodegenerative Disease Market Growth 2018-2023

October 2018 | 134 pages | ID: GE1E5A8B98BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Neurodegenerative Disease market for 2018-2023.

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.
Over the next five years, LPI(LP Information) projects that Neurodegenerative Disease will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurodegenerative Disease market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• NMDA
• SSRIs
• Dopamine Inhibitors

Segmentation by application:

• Parkinson’s Disease
• Huntington Disease
• Amyotrophic Lateral Sclerosis
• Alzheimer’s Disease

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Novartis
• Pfizer
• Merck Serono
• Biogen Idec
• TEVA
• UCB
• Boehringer Ingelheim
• Sanofi
• GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Neurodegenerative Disease consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Neurodegenerative Disease market by identifying its various subsegments.
• Focuses on the key global Neurodegenerative Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Neurodegenerative Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Neurodegenerative Disease submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neurodegenerative Disease Consumption 2013-2023
  2.1.2 Neurodegenerative Disease Consumption CAGR by Region
2.2 Neurodegenerative Disease Segment by Type
  2.2.1 NMDA
  2.2.2 SSRIs
  2.2.3 Dopamine Inhibitors
2.3 Neurodegenerative Disease Consumption by Type
  2.3.1 Global Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
  2.3.2 Global Neurodegenerative Disease Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Neurodegenerative Disease Sale Price by Type (2013-2018)
2.4 Neurodegenerative Disease Segment by Application
  2.4.1 Parkinson’s Disease
  2.4.2 Huntington Disease
  2.4.3 Amyotrophic Lateral Sclerosis
  2.4.4 Alzheimer’s Disease
2.5 Neurodegenerative Disease Consumption by Application
  2.5.1 Global Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
  2.5.2 Global Neurodegenerative Disease Value and Market Share by Application (2013-2018)
  2.5.3 Global Neurodegenerative Disease Sale Price by Application (2013-2018)

3 GLOBAL NEURODEGENERATIVE DISEASE BY PLAYERS

3.1 Global Neurodegenerative Disease Sales Market Share by Players
  3.1.1 Global Neurodegenerative Disease Sales by Players (2016-2018)
  3.1.2 Global Neurodegenerative Disease Sales Market Share by Players (2016-2018)
3.2 Global Neurodegenerative Disease Revenue Market Share by Players
  3.2.1 Global Neurodegenerative Disease Revenue by Players (2016-2018)
  3.2.2 Global Neurodegenerative Disease Revenue Market Share by Players (2016-2018)
3.3 Global Neurodegenerative Disease Sale Price by Players
3.4 Global Neurodegenerative Disease Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Neurodegenerative Disease Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Neurodegenerative Disease Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NEURODEGENERATIVE DISEASE BY REGIONS

4.1 Neurodegenerative Disease by Regions
  4.1.1 Global Neurodegenerative Disease Consumption by Regions
  4.1.2 Global Neurodegenerative Disease Value by Regions
4.2 Americas Neurodegenerative Disease Consumption Growth
4.3 APAC Neurodegenerative Disease Consumption Growth
4.4 Europe Neurodegenerative Disease Consumption Growth
4.5 Middle East & Africa Neurodegenerative Disease Consumption Growth

5 AMERICAS

5.1 Americas Neurodegenerative Disease Consumption by Countries
  5.1.1 Americas Neurodegenerative Disease Consumption by Countries (2013-2018)
  5.1.2 Americas Neurodegenerative Disease Value by Countries (2013-2018)
5.2 Americas Neurodegenerative Disease Consumption by Type
5.3 Americas Neurodegenerative Disease Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Neurodegenerative Disease Consumption by Countries
  6.1.1 APAC Neurodegenerative Disease Consumption by Countries (2013-2018)
  6.1.2 APAC Neurodegenerative Disease Value by Countries (2013-2018)
6.2 APAC Neurodegenerative Disease Consumption by Type
6.3 APAC Neurodegenerative Disease Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Neurodegenerative Disease by Countries
  7.1.1 Europe Neurodegenerative Disease Consumption by Countries (2013-2018)
  7.1.2 Europe Neurodegenerative Disease Value by Countries (2013-2018)
7.2 Europe Neurodegenerative Disease Consumption by Type
7.3 Europe Neurodegenerative Disease Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neurodegenerative Disease by Countries
  8.1.1 Middle East & Africa Neurodegenerative Disease Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Neurodegenerative Disease Value by Countries (2013-2018)
8.2 Middle East & Africa Neurodegenerative Disease Consumption by Type
8.3 Middle East & Africa Neurodegenerative Disease Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Neurodegenerative Disease Distributors
10.3 Neurodegenerative Disease Customer

11 GLOBAL NEURODEGENERATIVE DISEASE MARKET FORECAST

11.1 Global Neurodegenerative Disease Consumption Forecast (2018-2023)
11.2 Global Neurodegenerative Disease Forecast by Regions
  11.2.1 Global Neurodegenerative Disease Forecast by Regions (2018-2023)
  11.2.2 Global Neurodegenerative Disease Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Neurodegenerative Disease Forecast by Type
11.8 Global Neurodegenerative Disease Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Novartis
  12.1.1 Company Details
  12.1.2 Neurodegenerative Disease Product Offered
  12.1.3 Novartis Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Novartis News
12.2 Pfizer
  12.2.1 Company Details
  12.2.2 Neurodegenerative Disease Product Offered
  12.2.3 Pfizer Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Pfizer News
12.3 Merck Serono
  12.3.1 Company Details
  12.3.2 Neurodegenerative Disease Product Offered
  12.3.3 Merck Serono Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Merck Serono News
12.4 Biogen Idec
  12.4.1 Company Details
  12.4.2 Neurodegenerative Disease Product Offered
  12.4.3 Biogen Idec Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Biogen Idec News
12.5 TEVA
  12.5.1 Company Details
  12.5.2 Neurodegenerative Disease Product Offered
  12.5.3 TEVA Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 TEVA News
12.6 UCB
  12.6.1 Company Details
  12.6.2 Neurodegenerative Disease Product Offered
  12.6.3 UCB Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 UCB News
12.7 Boehringer Ingelheim
  12.7.1 Company Details
  12.7.2 Neurodegenerative Disease Product Offered
  12.7.3 Boehringer Ingelheim Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Boehringer Ingelheim News
12.8 Sanofi
  12.8.1 Company Details
  12.8.2 Neurodegenerative Disease Product Offered
  12.8.3 Sanofi Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Sanofi News
12.9 GlaxoSmithKline
  12.9.1 Company Details
  12.9.2 Neurodegenerative Disease Product Offered
  12.9.3 GlaxoSmithKline Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 GlaxoSmithKline News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurodegenerative Disease
Table Product Specifications of Neurodegenerative Disease
Figure Neurodegenerative Disease Report Years Considered
Figure Market Research Methodology
Figure Global Neurodegenerative Disease Consumption Growth Rate 2013-2023 (K Units)
Figure Global Neurodegenerative Disease Value Growth Rate 2013-2023 ($ Millions)
Table Neurodegenerative Disease Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of NMDA
Table Major Players of NMDA
Figure Product Picture of SSRIs
Table Major Players of SSRIs
Figure Product Picture of Dopamine Inhibitors
Table Major Players of Dopamine Inhibitors
Table Global Consumption Sales by Type (2013-2018)
Table Global Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Figure Global Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Table Global Neurodegenerative Disease Revenue by Type (2013-2018) ($ million)
Table Global Neurodegenerative Disease Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Neurodegenerative Disease Value Market Share by Type (2013-2018)
Table Global Neurodegenerative Disease Sale Price by Type (2013-2018)
Figure Neurodegenerative Disease Consumed in Parkinson’s Disease
Figure Global Neurodegenerative Disease Market: Parkinson’s Disease (2013-2018) (K Units)
Figure Global Neurodegenerative Disease Market: Parkinson’s Disease (2013-2018) ($ Millions)
Figure Global Parkinson’s Disease YoY Growth ($ Millions)
Figure Neurodegenerative Disease Consumed in Huntington Disease
Figure Global Neurodegenerative Disease Market: Huntington Disease (2013-2018) (K Units)
Figure Global Neurodegenerative Disease Market: Huntington Disease (2013-2018) ($ Millions)
Figure Global Huntington Disease YoY Growth ($ Millions)
Figure Neurodegenerative Disease Consumed in Amyotrophic Lateral Sclerosis
Figure Global Neurodegenerative Disease Market: Amyotrophic Lateral Sclerosis (2013-2018) (K Units)
Figure Global Neurodegenerative Disease Market: Amyotrophic Lateral Sclerosis (2013-2018) ($ Millions)
Figure Global Amyotrophic Lateral Sclerosis YoY Growth ($ Millions)
Figure Neurodegenerative Disease Consumed in Alzheimer’s Disease
Figure Global Neurodegenerative Disease Market: Alzheimer’s Disease (2013-2018) (K Units)
Figure Global Neurodegenerative Disease Market: Alzheimer’s Disease (2013-2018) ($ Millions)
Figure Global Alzheimer’s Disease YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Figure Global Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Table Global Neurodegenerative Disease Value by Application (2013-2018)
Table Global Neurodegenerative Disease Value Market Share by Application (2013-2018)
Figure Global Neurodegenerative Disease Value Market Share by Application (2013-2018)
Table Global Neurodegenerative Disease Sale Price by Application (2013-2018)
Table Global Neurodegenerative Disease Sales by Players (2016-2018) (K Units)
Table Global Neurodegenerative Disease Sales Market Share by Players (2016-2018)
Figure Global Neurodegenerative Disease Sales Market Share by Players in 2016
Figure Global Neurodegenerative Disease Sales Market Share by Players in 2017
Table Global Neurodegenerative Disease Revenue by Players (2016-2018) ($ Millions)
Table Global Neurodegenerative Disease Revenue Market Share by Players (2016-2018)
Figure Global Neurodegenerative Disease Revenue Market Share by Players in 2016
Figure Global Neurodegenerative Disease Revenue Market Share by Players in 2017
Table Global Neurodegenerative Disease Sale Price by Players (2016-2018)
Figure Global Neurodegenerative Disease Sale Price by Players in 2017
Table Global Neurodegenerative Disease Manufacturing Base Distribution and Sales Area by Players
Table Players Neurodegenerative Disease Products Offered
Table Neurodegenerative Disease Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Neurodegenerative Disease Consumption by Regions 2013-2018 (K Units)
Table Global Neurodegenerative Disease Consumption Market Share by Regions 2013-2018
Figure Global Neurodegenerative Disease Consumption Market Share by Regions 2013-2018
Table Global Neurodegenerative Disease Value by Regions 2013-2018 ($ Millions)
Table Global Neurodegenerative Disease Value Market Share by Regions 2013-2018
Figure Global Neurodegenerative Disease Value Market Share by Regions 2013-2018
Figure Americas Neurodegenerative Disease Consumption 2013-2018 (K Units)
Figure Americas Neurodegenerative Disease Value 2013-2018 ($ Millions)
Figure APAC Neurodegenerative Disease Consumption 2013-2018 (K Units)
Figure APAC Neurodegenerative Disease Value 2013-2018 ($ Millions)
Figure Europe Neurodegenerative Disease Consumption 2013-2018 (K Units)
Figure Europe Neurodegenerative Disease Value 2013-2018 ($ Millions)
Figure Middle East & Africa Neurodegenerative Disease Consumption 2013-2018 (K Units)
Figure Middle East & Africa Neurodegenerative Disease Value 2013-2018 ($ Millions)
Table Americas Neurodegenerative Disease Consumption by Countries (2013-2018) (K Units)
Table Americas Neurodegenerative Disease Consumption Market Share by Countries (2013-2018)
Figure Americas Neurodegenerative Disease Consumption Market Share by Countries in 2017
Table Americas Neurodegenerative Disease Value by Countries (2013-2018) ($ Millions)
Table Americas Neurodegenerative Disease Value Market Share by Countries (2013-2018)
Figure Americas Neurodegenerative Disease Value Market Share by Countries in 2017
Table Americas Neurodegenerative Disease Consumption by Type (2013-2018) (K Units)
Table Americas Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Figure Americas Neurodegenerative Disease Consumption Market Share by Type in 2017
Table Americas Neurodegenerative Disease Consumption by Application (2013-2018) (K Units)
Table Americas Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Figure Americas Neurodegenerative Disease Consumption Market Share by Application in 2017
Figure United States Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure United States Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Canada Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Canada Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Mexico Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Mexico Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Table APAC Neurodegenerative Disease Consumption by Countries (2013-2018) (K Units)
Table APAC Neurodegenerative Disease Consumption Market Share by Countries (2013-2018)
Figure APAC Neurodegenerative Disease Consumption Market Share by Countries in 2017
Table APAC Neurodegenerative Disease Value by Countries (2013-2018) ($ Millions)
Table APAC Neurodegenerative Disease Value Market Share by Countries (2013-2018)
Figure APAC Neurodegenerative Disease Value Market Share by Countries in 2017
Table APAC Neurodegenerative Disease Consumption by Type (2013-2018) (K Units)
Table APAC Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Figure APAC Neurodegenerative Disease Consumption Market Share by Type in 2017
Table APAC Neurodegenerative Disease Consumption by Application (2013-2018) (K Units)
Table APAC Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Figure APAC Neurodegenerative Disease Consumption Market Share by Application in 2017
Figure China Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure China Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Japan Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Japan Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Korea Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Korea Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure India Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure India Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Australia Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Australia Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Table Europe Neurodegenerative Disease Consumption by Countries (2013-2018) (K Units)
Table Europe Neurodegenerative Disease Consumption Market Share by Countries (2013-2018)
Figure Europe Neurodegenerative Disease Consumption Market Share by Countries in 2017
Table Europe Neurodegenerative Disease Value by Countries (2013-2018) ($ Millions)
Table Europe Neurodegenerative Disease Value Market Share by Countries (2013-2018)
Figure Europe Neurodegenerative Disease Value Market Share by Countries in 2017
Table Europe Neurodegenerative Disease Consumption by Type (2013-2018) (K Units)
Table Europe Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Figure Europe Neurodegenerative Disease Consumption Market Share by Type in 2017
Table Europe Neurodegenerative Disease Consumption by Application (2013-2018) (K Units)
Table Europe Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Figure Europe Neurodegenerative Disease Consumption Market Share by Application in 2017
Figure Germany Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Germany Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure France Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure France Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure UK Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure UK Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Italy Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Italy Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Russia Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Russia Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Spain Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Spain Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Neurodegenerative Disease Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Neurodegenerative Disease Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Neurodegenerative Disease Consumption Market Share by Countries in 2017
Table Middle East & Africa Neurodegenerative Disease Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Neurodegenerative Disease Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Neurodegenerative Disease Value Market Share by Countries in 2017
Table Middle East & Africa Neurodegenerative Disease Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Neurodegenerative Disease Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Neurodegenerative Disease Consumption Market Share by Type in 2017
Table Middle East & Africa Neurodegenerative Disease Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Neurodegenerative Disease Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Neurodegenerative Disease Consumption Market Share by Application in 2017
Figure Egypt Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Egypt Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure South Africa Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure South Africa Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Israel Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Israel Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure Turkey Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure Turkey Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Neurodegenerative Disease Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Neurodegenerative Disease Value Growth 2013-2018 ($ Millions)
Table Neurodegenerative Disease Distributors List
Table Neurodegenerative Disease Customer List
Figure Global Neurodegenerative Disease Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Neurodegenerative Disease Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Neurodegenerative Disease Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Neurodegenerative Disease Consumption Market Forecast by Regions
Table Global Neurodegenerative Disease Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Neurodegenerative Disease Value Market Share Forecast by Regions
Figure Americas Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Americas Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure APAC Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure APAC Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Europe Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Europe Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Middle East & Africa Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Middle East & Africa Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure United States Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure United States Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Canada Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Canada Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Mexico Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Mexico Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Brazil Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Brazil Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure China Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure China Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Japan Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Japan Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Korea Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Korea Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Southeast Asia Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Southeast Asia Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure India Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure India Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Australia Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Australia Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Germany Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Germany Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure France Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure France Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure UK Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure UK Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Italy Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Italy Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Russia Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Russia Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Spain Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Spain Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Egypt Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Egypt Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure South Africa Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure South Africa Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Israel Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Israel Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure Turkey Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure Turkey Neurodegenerative Disease Value 2018-2023 ($ Millions)
Figure GCC Countries Neurodegenerative Disease Consumption 2018-2023 (K Units)
Figure GCC Countries Neurodegenerative Disease Value 2018-2023 ($ Millions)
Table Global Neurodegenerative Disease Consumption Forecast by Type (2018-2023) (K Units)
Table Global Neurodegenerative Disease Consumption Market Share Forecast by Type (2018-2023)
Table Global Neurodegenerative Disease Value Forecast by Type (2018-2023) ($ Millions)
Table Global Neurodegenerative Disease Value Market Share Forecast by Type (2018-2023)
Table Global Neurodegenerative Disease Consumption Forecast by Application (2018-2023) (K Units)
Table Global Neurodegenerative Disease Consumption Market Share Forecast by Application (2018-2023)
Table Global Neurodegenerative Disease Value Forecast by Application (2018-2023) ($ Millions)
Table Global Neurodegenerative Disease Value Market Share Forecast by Application (2018-2023)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Neurodegenerative Disease Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Neurodegenerative Disease Market Share (2016-2018)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Serono Neurodegenerative Disease Market Share (2016-2018)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogen Idec Neurodegenerative Disease Market Share (2016-2018)
Table TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TEVA Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure TEVA Neurodegenerative Disease Market Share (2016-2018)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCB Neurodegenerative Disease Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Neurodegenerative Disease Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Neurodegenerative Disease Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Neurodegenerative Disease Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Neurodegenerative Disease Market Share (2016-2018)